07:38 EST Upstream Bio (UPB) files automatic mixed securities shelf
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UPB:
- Upstream Bio reports Q3 revenue $683k, consensus $516.8k
- Upstream Bio’s Promising Trials and Strategic Outlook Drive Buy Rating
- Upstream Bio’s COPD Study: A Potential Game-Changer for Investors
- Upstream Bio’s Verekitug Study: A Potential Game-Changer for Severe Asthma Treatment
- Upstream Bio initiated with a Buy at Truist